Publication:
Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency

dc.contributor.authorÖZEN, AHMET OĞUZHAN
dc.contributor.authorsTaghizade N., Babayeva R., Kara A., Karakus I. S., Catak M. C., Bulutoglu A., Haskologlu Z. S., Akay Haci I., Tunakan Dalgic C., Karabiber E., et al.
dc.date.accessioned2023-08-28T10:21:37Z
dc.date.accessioned2026-01-10T18:51:58Z
dc.date.available2023-08-28T10:21:37Z
dc.date.issued2023-08-16
dc.identifier.citationTaghizade N., Babayeva R., Kara A., Karakus I. S., Catak M. C., Bulutoglu A., Haskologlu Z. S., Akay Haci I., Tunakan Dalgic C., Karabiber E., et al., "Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.", The Journal of allergy and clinical immunology, 2023
dc.identifier.doi10.1016/j.jaci.2023.08.004
dc.identifier.issn0091-6749
dc.identifier.urihttps://hdl.handle.net/11424/292862
dc.language.isoeng
dc.relation.ispartofThe Journal of allergy and clinical immunology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleTherapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
3.97 MB
Format:
Adobe Portable Document Format